Patent details

EP2981255 Title: THERAPEUTIC USES OF EMPAGLIFLOZIN

Basic Information

Publication number:
EP2981255
PCT Application Number:
EP2014056655
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP147152748
PCT Publication Number:
WO2014161918
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
THERAPEUTIC USES OF EMPAGLIFLOZIN
French Title of Invention:
UTILISATIONS THÉRAPEUTIQUES D'EMPAGLIFLOZINE
German Title of Invention:
THERAPEUTISCHE VERWENDUNGEN VON EMPAGLIFLOZIN
SPC Number:

Dates

Filing date:
03/04/2014
Grant date:
14/09/2022
EP Publication Date:
10/02/2016
PCT Publication Date:
09/10/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/09/2022
EP B1 Publication Date:
14/09/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
03/04/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
07/09/2022
 
 

Name:
Boehringer Ingelheim International GmbH
Address:
Binger Strasse 173, 55216 Ingelheim am Rhein, Germany (DE)

Inventor

1

Name:
SALSALI, Afshin
Address:
United States (US)

2

Name:
WOERLE, Hans-Juergen
Address:
Germany (DE)

3

Name:
SOLEYMANLOU, Nima
Address:
Canada (CA)

4

Name:
JOHANSEN, Odd-Erik
Address:
Norway (NO)

5

Name:
CHERNEY, David
Address:
Canada (CA)

6

Name:
MUENZEL, Thomas
Address:
Germany (DE)

7

Name:
MAYOUX, Eric Williams
Address:
Germany (DE)

8

Name:
PERKINS, Bruce A.
Address:
Canada (CA)

9

Name:
BROEDL, Uli Christian
Address:
Germany (DE)

10

Name:
KIM, Gabriel Woojai
Address:
Germany (DE)

11

Name:
DAIBER, Andreas
Address:
Germany (DE)

12

Name:
VON EYNATTEN, Maximilian
Address:
Germany (DE)

Priority

1

Priority Number:
201361808807 P
Priority Date:
05/04/2013
Priority Country:
United States (US)

2

Priority Number:
2812016
Priority Date:
10/04/2013
Priority Country:
Canada (CA)

3

Priority Number:
201361823041 P
Priority Date:
14/05/2013
Priority Country:
United States (US)

4

Priority Number:
201361835811 P
Priority Date:
17/06/2013
Priority Country:
United States (US)

5

Priority Number:
201361835809 P
Priority Date:
17/06/2013
Priority Country:
United States (US)

6

Priority Number:
201461942301 P
Priority Date:
20/02/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/155; A61K 31/522; A61K 31/7048; A61P 9/10; A61P 3/10; A61K 45/06;

Publication

European Patent Bulletin

Issue number:
202237
Publication date:
14/09/2022
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
30/04/2026
Annual Fee Number:
13
Annual Fee Amount:
180 Euro
Expected Payer:
Last Annual Fee Payment Date:
18/04/2025
Last Annual Fee Paid Number:
12
Last Annual Fee Paid Amount:
165 Euro
Payer:
DENNEMEYER & CO
Filing date Document type Number of pages